Top Markets
Coin of the day
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Rank in Stocks #29361
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Share Price
$0.365
Last synced: 2025-08-01
Market Cap
$21.54M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Elevation Oncology, Inc. (ELEV)

Category

Price of ELEV with the market cap of B
Elevation Oncology, Inc. Elevation Oncology, Inc.
ELEV
$0.365
Market Capitalization of Elevation Oncology, Inc.(ELEV)
Market Cap: $21.54M
As of August 2026 Elevation Oncology, Inc. has a market cap of $21.54M. This makes Elevation Oncology, Inc. the world's 29361st most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Elevation Oncology, Inc. from 2021 to 2026
ELEV compared with Top 5 Most Popular stocks
Price of ELEV Asset B Mkt. of B Results
Elevation Oncology, Inc. Elevation Oncology, Inc.
$90,338.83 $21.54M
$5.332T +24,750,264.06%
Elevation Oncology, Inc. Elevation Oncology, Inc.
$77,298.68 $21.54M
$4.562T +21,177,619.30%
Elevation Oncology, Inc. Elevation Oncology, Inc.
$70,177.18 $21.54M
$4.142T +19,226,525.54%
Elevation Oncology, Inc. Elevation Oncology, Inc.
$60,678.09 $21.54M
$3.581T +16,624,033.84%
Elevation Oncology, Inc. Elevation Oncology, Inc.
$47,258.21 $21.54M
$2.789T +12,947,353.94%